Skip to content

Minimally invasive surfactant therapy and diaphragm activity in preterm infants

Minimally invasive surfactant therapy and diaphragm activity in preterm infants - Minimally invasive surfactant therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46170
Enrollment
20
Registered
2016-05-24
Start date
2016-06-22
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome respiratory problems of newborn preterm infants

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Born at gestational age

Exclusion criteria

Exclusion criteria: - Major congenital anomalies - The attending physician considers the infant to be too vulnerable to participate in the study

Design outcomes

Primary

MeasureTime frame
Changes in electrical activity of the diaphragm after MIST

Secondary

MeasureTime frame
Changes in Vt after MIST The correlation of changes in diaphragm activity and changes in Vt after MIST.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)